Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Molecular characterization of a novel putative pathogen, Streptococcus nakanoensis sp. nov., isolated from sputum culture.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE
- Publication Information:
Original Publication: Washington, DC : ASM Press, 2013-
- Subject Terms:
- Abstract:
Reports of novel species of α-hemolytic Streptococcus have increased recently. However, limited information exists regarding the pathogenicity of these species, with the exception of Streptococcus pneumoniae and Streptococcus pseudopneumoniae . In this study, a quinolone-resistant α- Streptococcus strain, MTG105, was isolated from the sputum of a patient with pneumonia. This strain was first identified as S. pneumoniae at the hospital laboratory; however, it exhibited unique genetic features upon further analysis. Digital DNA-DNA hybridization and average nucleotide identity based on BLAST values from whole-genome sequencing revealed MTG105 to be a novel species closely related to S. pseudopneumoniae . Although MTG105 carried two copies of the pneumolysin gene, similar to S. pseudopneumoniae , this isolate exhibited susceptibility to optochin under both aerobic and 5% CO 2 conditions. Notably, no biochemical features could be used to definitively identify this species. In an infection assay using organotypic lung tissue models, MTG105 induced epithelial damage comparable to that of S. pneumoniae and S. pseudopneumoniae , possibly suggesting its potential as a pathogenic α- Streptococcus . The natural transformation abilities of Streptococcus species facilitate their exchange of genes within the same genus, resulting in the existence of species with increasingly more diverse genome structures. Therefore, the identification of this species highlights the importance of monitoring the emergence of novel species exhibiting virulence and/or multidrug resistance. This isolate was proposed as a novel species, designated Streptococcus nakanoensis sp. nov. The type strain was MTG 105 T (= JCM 35953 T = CCUG 76894 T ).
Importance: The genus Streptococcus encompasses a wide range of bacteria with more than 60 species. Recently, there has been a notable increase in reports of novel species of α- Streptococcus based on genomic analysis data. However, limited information exists regarding the pathogenicity of these species. In this study, a quinolone-resistant α-hemolytic Streptococcus strain, MTG105, was isolated from a patient with pneumonia. Genetic analysis revealed that this species was a novel species closely related to S. pseudopneumoniae . In an infection assay using organotypic lung tissue models, MTG105 induced epithelial damage comparable to that caused by S. pneumoniae and S. pseudopneumoniae , strongly suggesting its potential as a pathogenic α- Streptococcus . The natural transformation abilities of Streptococcus species facilitate gene exchange within the same genus, leading to the emergence of species with increasingly diverse genome structures. Therefore, the identification of this species underscores the importance of monitoring the emergence of novel species exhibiting virulence and/or multidrug resistance.
Competing Interests: The authors declare no conflict of interest.
- References:
J Bacteriol. 1997 Nov;179(21):6589-94. (PMID: 9352904)
Mol Microbiol. 2015 Sep;97(5):866-80. (PMID: 26010014)
mBio. 2014 Jul 22;5(4):e01490-14. (PMID: 25053789)
Microbiol Mol Biol Rev. 2009 Sep;73(3):407-50, Table of Contents. (PMID: 19721085)
Arch Microbiol. 2022 Sep 29;204(10):654. (PMID: 36175573)
J Pediatric Infect Dis Soc. 2023 Jul 31;12(7):381-391. (PMID: 37490409)
J Microbiol. 2021 Aug;59(8):792-806. (PMID: 34302622)
Cell Host Microbe. 2021 Jun 9;29(6):867-878. (PMID: 34111395)
mBio. 2019 Jun 25;10(3):. (PMID: 31239383)
Sci Rep. 2017 Aug 2;7(1):7167. (PMID: 28769078)
Dis Model Mech. 2015 Nov;8(11):1413-25. (PMID: 26398950)
J Glob Antimicrob Resist. 2019 Sep;18:104-108. (PMID: 30753907)
Arch Microbiol. 2021 Nov;203(9):5475-5482. (PMID: 34417650)
Int J Microbiol. 2023 Aug 1;2023:3802590. (PMID: 37559874)
Microb Drug Resist. 1997 Spring;3(1):27-37. (PMID: 9109094)
Cell Rep. 2024 Mar 26;43(3):113962. (PMID: 38483905)
Curr Microbiol. 2021 Jul;78(7):2821-2827. (PMID: 34031726)
Microbiol Spectr. 2016 Aug;4(4):. (PMID: 27726779)
J Glob Antimicrob Resist. 2022 Jun;29:316-322. (PMID: 35500839)
Front Microbiol. 2020 Sep 29;11:563213. (PMID: 33133039)
Res Microbiol. 2007 Dec;158(10):767-78. (PMID: 17997281)
Diagn Microbiol Infect Dis. 2000 Aug;37(4):285-7. (PMID: 10974582)
Curr Microbiol. 2019 Jul;76(7):835-841. (PMID: 31053905)
Curr Opin Infect Dis. 2002 Jun;15(3):235-9. (PMID: 12015456)
Mol Microbiol. 2022 Mar;117(3):682-692. (PMID: 34605588)
Curr Microbiol. 2019 Oct;76(10):1193-1198. (PMID: 31332483)
Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0117923. (PMID: 38415648)
Ann Rheum Dis. 2021 May;80(5):573-581. (PMID: 33397732)
Clin Microbiol Rev. 2002 Oct;15(4):613-30. (PMID: 12364372)
J Vis Exp. 2015 Oct 05;(104):. (PMID: 26485646)
Arch Microbiol. 2022 Jun 3;204(7):359. (PMID: 35657449)
Microbiol Resour Announc. 2019 Jan 24;8(4):. (PMID: 30701262)
Antimicrob Agents Chemother. 2002 Mar;46(3):680-8. (PMID: 11850248)
Arch Microbiol. 2022 Nov 27;205(1):3. (PMID: 36436132)
FEMS Microbiol Lett. 1993 Jul 1;110(3):335-9. (PMID: 8354467)
Arch Microbiol. 2024 Mar 15;206(4):168. (PMID: 38489085)
Antonie Van Leeuwenhoek. 2021 Feb;114(2):113-127. (PMID: 33387140)
PLoS One. 2013;8(2):e57047. (PMID: 23437306)
J Infect Public Health. 2020 Apr;13(4):497-501. (PMID: 31839585)
Int J Syst Bacteriol. 1995 Apr;45(2):406-8. (PMID: 7537076)
Emerg Infect Dis. 2022 Jan;28(1):104-110. (PMID: 34932443)
Curr Microbiol. 2019 Dec;76(12):1531-1536. (PMID: 31570960)
Front Cell Infect Microbiol. 2024 Feb 22;14:1357631. (PMID: 38456080)
Int J Syst Evol Microbiol. 2020 Jul;70(7):4098-4104. (PMID: 32539911)
J Antimicrob Chemother. 2011 Mar;66(3):476-86. (PMID: 21193474)
J Exp Med. 1933 Mar 31;57(4):571-95. (PMID: 19870148)
Proc Natl Acad Sci U S A. 1990 Aug;87(15):5858-62. (PMID: 2377622)
- Grant Information:
19K08964 MEXT | Japan Society for the Promotion of Science (JSPS); Encouragement Award Japan Antibiotic Research Association
- Contributed Indexing:
Keywords: Streptococcus; multidrug resistance; pathogenesis
- Accession Number:
0 (Anti-Bacterial Agents)
0 (Streptolysins)
4W030VS2OG (ethylhydrocupreine)
0 (Bacterial Proteins)
A7V27PHC7A (Quinine)
- Publication Date:
Date Created: 20240913 Date Completed: 20241004 Latest Revision: 20241012
- Publication Date:
20241012
- Accession Number:
PMC11465973
- Accession Number:
10.1128/spectrum.01354-24
- Accession Number:
39269180
No Comments.